References
[1] Shah B.N., Nayak, B.S., Seth A.K., et al. (2006). Medicinal plants as a source of anti-inflammatory and anti-arthritic agents - A review. Pharmacognosy Magazine, 2 (6), 77–86.
[2] Young, A., Thomson, A. J., Ledingham, M., Jordan, F., Greer, I.A., Norman, J. E. (2002). Immunolocalization of proinflam-matory cytokines in myometrium, cervix, and fetal membranes during human parturition at term1. Biology of Reproduction, 66 (2), 445-449.
[3] Richard, F., Luigi, X., Cubeddu-Michelle, A. C. (2009). Lippincott’s Illustrated Reviews Bundle, Lippincott’s Illustrated Reviews: Biochemistry, 4th Ed. Lippincott’s. Lippincott Williams & Wilkins.
[4] Rang, H.P., Dale, M.M., Lamb, P., Ritter, J.M., Moore, P. (2003). Pharmacology. Churchill Livingstone.
[5] Craig, C.R., Stitzel, R.E. (2003). Modern pharmacology: clinical applications. Philadelphia, Pa.; London: Lippincott Williams & Wilkins.
[6] Kumar, V., Abbas, A., Aster, J. (2010). Robbins and Cotran’s Pathologic Basis of Disease, 7th Edition. American Journal of Surgical Pathology, 34, 132.
[7] Richardson, K.T. (1971). Pharmacology and pathophysiology of inflammation. Archives of Ophthalmology, 86 (6), 706–724.
[8] Kumar, R., Clermont, G., Vodovotz, Y., Chow, C.C. (2004). The dynamics of acute inflammation. Journal of Theoretical Biology, 230 (2), 145–155.
[9] Cottam, D.R., Mattar, S.G., Barinas-Mitchell, E., et al. (2004). The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effect of weight loss. Obesity Surgery, 14 (5), 589-600.
doi: 10.1381/096089204323093345.
[10] Wu, J.T., Wu, L. L. (2007). Acute and chronic inflammation: Effect of the risk factor(s) on the progression of the early inflammatory response to the oxidative and nitrosative stress. Measurement, 19 (3), 71–75.
[11] Kamboj, V.P. (2000). Herbal medicine. Current Science, 78 (1), 35–39.
[12] Wang, M.Y., West, B.J., Jensen, C.J., et al. (2002). Morindacitrifolia (Noni): A literature review and recent advances in Noni research. Acta PharmacologicaSinica, 23 (12), 1127-1141.
[13] Verma, S., Singh, S.P. (2008). Current and future status of herbal medicines. Veterinary World, 2(2), 347-350.
[14] Association, B.M. (1993). Complementary Medicine: New Approaches to Good Practice. Oxford; New York, Oxford University Press.
[15] Boullata, J.I., Nace, A.M. (2000). Safety issues with herbal medicine. Pharmacotherapy 20, 357-69.
doi: 10.1592/phco.20.4.257.34886.
[16] Bent, S., Ko, R. (2004). Commonly used herbal medicines in the United States: A review. American Journal of Medicine, 116 (7), 478-485. doi: 10.1016/j.amjmed.2003.10.036.
[17] Sherman, K. J. (2005). Complementary and alternative medicine in the United States. American College of Physicians. Annals of Internal Medicine; Philadelphia, 143 (9), e-ISSN: 15393704.
[18] Drew, A.K., Myers, S.P. (1997). Safety issues in herbal medicine: Implications for the health professions. Medical Journal of Australia, 166 (10), 538-541.
[19] Singh, A., Malhotra, S., Subban, R. (2008). Anti-inflammatory and analgesic agents from Indian medicinal plants. International Journal of Integrative Biology, 3 (1), 57-72.
[20] Ghasemian, M., Owlia, S., Owlia, M.B. (2016). Review of anti-inflammatory herbal medicines. Advances in Pharmacological Sciences, 2016: 9130979. doi: 10.1155/2016/9130979.
[21] Dharmananda, S. (2001). Safety issues affecting herbs: Pyrrolizidine alkaloids. http://www.itmonline.org/arts/pas.htm. As accessed on 18th April 2022.
[22] Bianco, V.V., Santamaria, P., Elia, A. (1998). Nutritional value and nitrate content in edible wild species used in southern Italy. Acta Horticulturae, 467, 71-87.
[23] Larson, K.M., Roby, M.R., Stermitz, F.R. (1984). Unsaturated pyrrolizidines from borage (Borago officinalis), A common garden herb. Journal of Natural Products, 47(4), 747-748. http://doi.org/10.1021/np50034a045.
[24] Gupta, M., Singh, S. (2010). Borago officinalis Linn. An important medicinal plant of Mediterranean region: Review. International Journal of Pharmaceutical Sciences Review and Research, 5, 27-34.
[25] Al-Khamees, W.A., Schwartz, M.D., Alrashdi, S., Algren, A.D., Morgan, B.W. (2011). Status epilepticus associated with Borage Oil ingestion. Journal of Medical Toxicology, 7,154-157. doi: 10.1007/s13181-011-0135-9.
[26] Asadi-Samani, M., Bahmani, M., Rafieian-Kopaei, M. (2014). The chemical composition, botanical characteristic and biological activities of Borago officinalis: A review. Asian Pac J Trop Med, 7, S22–S28.
[27] Kast RE. (2001). Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha. International Immunopharmacology, 1(12):2197-9. doi: 10.1016/s1567-5769(01)00146-1.
[28] Deodhar, S.D., Sethi, R., Srimal, R.C. (1980). Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian Journal of Medical Research, 71(4), 632-634.
[29] Bundy, R., Walker, A.F., Middleton, R.W., Booth, J. (2004). Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. Journal of Alternative and Complementary Medicine, 10 (6), 1015-1018.
[30] Hanai, H., Iida, T., Takeuchi, K., et al. (2006). Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology, 4 (12), 1502-1506.
[31] Taheri, B. J., Anbari, F., Maleki, Z., et al. (2010). Efficacy of Elaeagnus angustifolia tropical gel in the treatment of symptomatic oral Lichen Planus. Journal of Dental Research, Dental Clinics, Dental Prospects, 4(1), 29-32.
[32] Ahmadiani, A., Hosseiny, J., Semnanian, S., et al. (2000). Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. Journal of Ethnopharmacology, 72 (1-2), 287-292. doi: 10.1016/s0378-8741(00)00222-1.
[33] Farahbakhsh, S., Arbabian, S., Emami, F., et al. (2011). Inhibition of cyclooxygenase type 1 and 2 enzymes by aqueous extract of Elaeagnus angustifolia in mice. Basic and Clinical Neuroscience, 2(2), 31-37.
[34] Gyurkovska, V., Alipieva, K., Maciuk, A., et al. (2011). Anti-inflammatory activity of Devil’s claw in vitro systems and their active constituents. Food Chemistry, 125 (1), 175-178.
[35] Fiebich, B.L., Fiebich, B.L., Heinrich, M., Hiller, K.O., Kammerer, N. (2001). Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHan 69. Phytomedicine, 8 (1), 28–30.
[36] Loew, D., Mollerfeld, J., Schrodter, A., Puttkammer, S., Kaszkin, M. (2001). Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in-vitro and ex-vivo. Clinical Pharmacology and Therapeutics, 69 (5), 356-364. doi.org/10.1067/mcp.2001.115445.
[37] Loew, D., Mollerfeld, J., Schrodter, A., Puttkammer, S., Kaszkin, M. (2001). Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in-vitro and ex-vivo. Clinical Pharmacology and The-rapeutics, 69 (5), 356-364. doi.org/10.1067/mcp.2001.115445.
[38] Setty, A.R., Sigal, L.H. (2005). Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism, 34(6), 773-784. doi: 10.1016/j.semarthrit.2005.01.011.
[39] Adeyemi, O. O., Okpo, S. O., Ogunti, O. O. (2002). Analgesic and anti-inflammatory effects of the aqueous extract of leaves of Persea americana Mill (Lauraceae). Fitoterapia, 73 (5), 375–380.
[40] Borghi, A., Corazza, M., Minghetti, S., Toni, G., Virgili, A. (2015). Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: Results of efficacy and tolerability. J Eur Acad Dermatology Venereol, 29, 1225-1230.
[41] Montserrat-De, L. P. S., Fernandez-Arche, M.A., Angel-Martin, M., Garca-Gimenez, M.D. (2014). Phytochemical characteri-zation of potential nutraceutical ingredients from evening primrose oil (Oenothera biennis L.). Phytochemistry Letters, 8(1), 158-162.
[42] Bogani, P., Galli, C., Villa, M., Visioli, F. (2007). Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis, 190 (1), 181-186.
[43] Camargo, A., Rangel-Zuniga, O.A., Haro, C., et al. (2014). Olive oil phenolic compounds decrease the postprandial inflammatory response by reducing postprandial plasma lipopolysaccharide levels. Food Chemistry, 162, 161-171.
[44] Najmi, M., Shariatpanahi, Z.V., Tolouei, M., Amiri, Z. (2015). Effect of oral olive oil on healing of 10-20% total body surface area burn wounds in hospitalized patients. Burns, 41(3), 493-496.
[45] Gopalan, A., Reuben, S. C., Ahmed, S., Darvesh, A. S., Hohmannb, J., Bishayee, A. (2012). The health benefits of blackcurrants. Food Funct, 3, 795-809. doi: 10.1039/c2fo30058.
[46] Watson, J., Byars, M.L., Mcgill, P., Kelman, A.W. (1993). Cytokine and prostaglandin production by monocytes of volunteers and rheumatoid arthritis patients treated with dietary supplements of blackcurrant seed oil. Rheumatology, 32(12), 1055-1058.
[47] Bishayee, A., Thoppil, R.J., Mandal, A., et al. (2013). Black currant phytoconstituents exert chemoprevention of diethyl nitro-samine-initiated hepatocarcinogenesis by suppression of the inflammatory response. Molecular Carcinogenesis, 52(4), 303-317.
[48] Winther, K., Campbell-Tofte, J., Vinther- Hansen, A.S. (2016). Bioactive ingredients of rose hips (Rosa canina L.) with special reference to antioxidative and anti-inflammatory properties: in-vitro studies. Botanics: Targets and Therapy, 2016 (6), 11-23.
[49] Kultur, S. (2007). Medicinal plants used in Kirklareli Province (Turkey). Journal of ethnopharmacology, 111 (2), 341-364.
[50] Yeşilada, E., Ustün, O., Sezik, E., Takaishi, Y., Ono, Y., Honda, G. (1997). Inhibitory effects of Turkish folk remedies on in-flammatory cytokines: Interleukin-1α, interleukin-1β and tumor necrosis factor α. Journal of Ethnopharmacology, 58(1), 59-73.
[51] Carle, R., Gomma, K. (1991). Medicinal uses of Matricariae Flos. British Journal of Phytotherapy, 2 (4), 147–153.
[52] Ninomiya, K., Matsuda, H., Kubo, M., Morikawa, T., Nishida, N., Yoshikawa, M. (2007). Potent anti-obese principle from Rosa canina: Structural requirements and mode of action of trans-tiliroside. Bioorganic and Medicinal Chemistry Letters, 17(11), 3059–3064.
[53] Nagatomo, A., Nishida, N., Fukuhara, I., et al. (2015). Daily intake of rosehip extract decreases abdominal visceral fat in pre-obese subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2015 (8), 147-156.
[54] Larsen, E., Kharazmi, A., Christensen, L. P., Christensen, S.B. (2003). An anti-inflammatory galactolipid from rose hip (Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitro. Journal of Natural Products, 66(7), 994-995.
[55] Jager, A. K., Eldeen, I.M.S., Van-Staden, J. (2007). COX-1 and -2 activity of rose hip.
Phytotherapy Research, 21(12), 1251-1252.
[56] Jager, A.K., Petersen, K.N., Thomasen, G., Christensen, S.B. (2008). Isolation of linoleic and α-linolenic acids as COX-1 and -2 inhibitors in rose hip. Phytotherapy Research, 22 (7), 982-984. doi: 10.1002/ptr.2446.
[57] Marstrand, C., Warholm, L., Kharazmi, A., Winther, K. (2013). The anti-inflammatory capacity of Rose-hip is strongly dependent on the seeds - A comparison of animal and human studies. Osteoarthritis and Cartilage, 21, S216-S217.
[58] Winther, K. (2014). Shells from rose-hip (Rosa canina) do not reduce symptom scores or improve anti-inflammatory property in patients with osteoarthritis-a double-blind, placebo-controlled, randomized study. Osteoarthritis and Cartilage, 22, S321. doi:10.1016/j.joca.2014.02.594.
[59] Borges, R. S., Ortiz, B.L.S., Pereira, A.C.M., et al. (2019). Rosmarinus officinalis essential oil: A review of its phytochemistry, anti-inflammatory activity, and mechanisms of action involved. Journal of Ethnopharmacology, 229, 29-45.
[60] Amaral, G.P., de-Carvalho, N.R., Barcelos, R.P., et al. (2013). Protective action of ethanolic extract of Rosmarinus officinalis L. in gastric ulcer prevention induced by ethanol in rats. Food and Chemical Toxicology, 55, 48-55.
doi: 10.1016/j.fct.2012.12.038.
[61] Hamidpour, M., Hamidpour, R., Hamidpour, S., Shahlari, M. (2014). Chemistry, pharmacology, and medicinal property of sage (salvia) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer. Journal of Traditional and Complementary Medicine, 4 (2), 82-88. doi: 10.4103/2225-4110.130373.
[62] Fawzi, M., Kamel, Z., Farhan, S. (2017). Anti-inflammatory effect of Sage (Salvia officinalis) extracts; Abstract on Oral Health. Iraqi Dent J, 39 (1), 1. doi:10.26477/idj.v39i1.111.
[63] Poeckel, D., Greiner, C., Verhoff, M., et al. (2008). Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochemical Pharmacology, 76 (1), 91-97.
[64] Carrasco, F.R., Schmidt, G., Romero, A.L., et al. (2009). Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygiumaromaticum L. essential oils: Evidence for humor-and cell-mediated responses. Journal of Pharmacy and Pharmacology, 61(7), 961-967.
[65] Rodrigues, M.R.A., Kanazawa, L.K.S., Neves., et al. (2012). Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice. Journal of Ethnopharmacology, 139 (2), 519-126.
[66] Rasool, M., Sabina, E. P., Lavanya, B. (2006). Anti-inflammatory effect of Spirulina fusiformis on adjuvant-induced arthritis in mice. Biological and Pharmaceutical Bulletin, 29 (12), 2483-2487.
[67] Beg, S., Swain, S., Hasan, H., et al. (2011). Systematic review of herbals as potential anti-inflammatory agents: Recent advances, current clinical status and future perspectives. Pharmacogn Rev, 5 (10), 120–137.
[68] Johnson, T.A., Sohn, J., Inman, W.D., Bjeldanes, L. F., Rayburn, K. (2013). Lipophilic stinging nettle extracts possess potent anti-inflammatory activity, are not cytotoxic and may be superior to traditional tinctures for treating inflammatory disorders. Phytomedicine, 20 (2), 143–147.
[69] Batiha, G. E., Beshbishy, A. M., Wasef, L., et al. (2010). Uncaria tomentosa (Willd. ex Schult.) DC.: A review on chemical constituents and biological activities. Appl Sci 10, 2668. doi:10.3390/app10082668.
[70] Piscoya, J., Rodriguez, Z., Bustamante, S. A., et al. (2001). Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: Mechanisms of action of the species Uncariaguianensis. Inflammation Research, 50 (9), 442–448.
[71] Kolehmainen, M., Mykkanen, O., Kirjavainen, P.V., et al. (2012). Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Molecular Nutrition and Food Research, 56 (10), 1501-1510.
[72] Hoggard, N., Cruickshank, M., Moar, K.M., et al. (2013). A single supplement of a standardized bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle. Journal of Nutritional Science, 2: e22. doi: 10.1017/jns.2013.16.
[73] Ueda, H., Ippoushi, K., Takeuchi, A. (2010). Repeated oral administration of a squeezed ginger (Zingiber officinale) extract augmented the serum corticosterone level and had anti-inflammatory properties. Bioscience, Biotechnology and Biochemistry, 74(11), 2248–2252.
[74] Mahluji, S., Ostadrahimi, A., Mobasseri, M., Attari, V.E., Payahoo, L. (2013). Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients. Advanced Pharmaceutical Bulletin, 3 (2), 273-276.
[75] Shirin, A. P. R., Prakash, J. (2010). Chemical composition and antioxidant properties of ginger root (Zingiber officinale). J Med Plant Res, 4 (24), 2674-2679. doi: 10.5897/JMPR09.464.
[76] Haghighi, A., Tavalaei, N., Owlia, M.B. (2006). Effects of ginger on primary knee osteoarthritis. Indian Journal of Rheumatology, 1(1), 3-7.
[77] Haghighi, M., Khalvat, A., Toliat, T., Jallaei, S. (2005). Comparing the effects of ginger (Zingiber officinale) extract and ibu-profen on patients with osteoarthritis. Archives of Iranian Medicine, 8(4), 267-271.
[78] Srivastava, K.C., Mustafa, T. (1992). Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Medical Hypotheses, 39 (4), 25-28.
[79] Dhale, A. D., Bhoi, S.S. (2013). Pharmacognostic characterization and phytochemical screening of Achyranthes aspera Linn. Current Agriculture Research Journal, 1(1), 51-57. http://dx.doi.org/10.12944/CARJ.1.1.07.
[80] Hasan, S. (2014). Pharmacological and Medicinal Uses of Achyranthes Aspera. Int J Sci Environ Technol, 3, 123-129.
[81] Chougule., Bhupal, S., Patil, A. B., et al. (2021). A Review of Apamarg (Achyranrhes aspera ) with reference to Visha Chikitsha (anti-poisonous effect). International Journal of Scientific Research, 10, 45–47.
[82] Gupta, V., Krishna, C.M., Bansal, P., Kumar, S., Prasad, G.P., Ravi-Krishna, D.V. (2010). Phytochemistry and Pharmacological Potential of Achyranthes aspera- A review. Int. J. Ayurvedic Med, 1, 1–11. doi:10.47552/ijam.v1i1.
[83] Vetrichelvan T, Jegadeesan M. (2003). Effect of alcohol extract of Achyranthes aspera Linn. on acute and subacute inflammation. Phytotherapy Research, 17 (1): 77-79.
[84] Bhosale, U., Pophale, P., Somani, R., Yegnanarayan, R. (2012). Effect of aqueous extracts of Achyranthes aspera Linn. on experimental animal model for inflammation. Anc Sci Life, 31 (4), 202-206.
[85] Sohani, S. (2020). Ethno-medicinal uses and chemical constituents of Indian flora: Achyranthes aspera (Latjeera). International Journal of Science and Research, 9 (4), 1778-1780.
[86] Mukherjee, H., Ojha, D., Bag, P., Chandel, H. S., et al. (2013). Anti-herpes virus activities of Achyranthes aspera: An Indian ethnomedicine, and its triterpene acid. Microbiol Res, 168 (4), 238-244.
[87] Mothes, W., Sherer, N.M., Jin, J., Zhong, P. (2010). Virus cell-to-cell transmission. Journal of Virology, 84 (17), 8360-8368. https://doi.org/10.1128/JVI.00443-10.
[88] Palshetkar, A., Pathare, N., Jadhav, N., et al. (2020). in-vitro anti-HIV activity of some Indian medicinal plant extracts. BMC Complementary Medicine and Therapies, 20 (69). https://doi.org/10.1186/s12906-020-2816-x.
[89] Dutta, T., Ghorai, S., Khan, A. A., Baildya, N., Ghosh, N.N. (2021). Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study. Journal of Physics: Conference Series. 1797 (2021) 012042.
[90] Jayakumar, T., Sridhar, M.P., Bharathprasad T.R., Ilayaraja, M., Govindasamy, S., Balasubramanian, M.P. (2009). Experimental studies of Achyranthes aspera (L) preventing nephrotoxicity induced by lead in albino rats. Journal of Health Science, 55 (5), 701–708.
[91] Girach-Aminuddin, R.D., Khan, S.A (1992). Ethnomedicinal uses of Achyranthes aspera L. in Orissa (India). International Journal of Pharmacognosy, 30 (2), 113–115.
[92] Sebastian, M.K., Bhandari, M. M. (1984). Medico-ethnobotany of Mount Abu, Rajasthan, India. Journal of Ethnopharmacology, 12(2), 223-230.
[93] Anis, M., Iqbal, M. (1994). Medicinal plant-lore of Aligarh, India. Pharmaceutical Biology, 32 (1), 59-64.
https://doi.org/10.3109/13880209409082973.
[94] Reddy, M.B., Reddy, K. R., Reddy, M. N. (1988). A survey of medicinal plants of Chenchu tribes of Andhra Pradesh, India. Pharmaceutical Biology, 26 (4), 189-196.
[95] Pal, D. C., Jain, S. K. (1989). Notes on Lodha medicine in Midnapur District, West Bengal, India. Economic Botany, 43(4), 464-470.
[96] Neogi, N., Rathor, R., Shrestha, A., Banerjee, D. (1969). Studies on the anti-inflammatory and anti-arthritic activity of achyranthine. Indian Journal of Pharmacology, 1 (3), 37–48.
[97] Ngo, L.T., Okogun, J.I., Folk, W.R. (2013). 21st Century natural product research and drug development and traditional medicines. Natural Product Reports, 30 (4), 584-592.
[98] Ramaiah, M., Chakravathi, G., Yasaswini, K. (2013). In-vitro biological standardization, formulation and evaluation of directly compressed polyherbal anthelmintic tablets. Pharmacogn, J 5(3), 130-134.
[99] Karole, S., Shrivastava, S., Thomas, S., et al. (2019). Polyherbal Formulation concept for synergic action: A review. J Drug Deliv Ther, 9, 453–66.
[100] Ajazuddin., Saraf, S. (2010). Evaluation of physicochemical and phytochemical properties of Safoof-E-Sana, a Unani polyherbal formulation. Pharmacognosy Res, 2 (5), 318-22. doi: 10.4103/0974-8490.72332.
[101] Spinella, M. (2002). The importance of pharmacological synergy in psychoactive herbal medicines. Altern Med Rev, 7 (2), 130-137.
[102] Parasuraman, S., Thing, G.S., Dhanaraj, S.A. (2014). Polyherbal formulation: Concept of Ayurveda. Pharmacognosy Reviews, 8 (16), 73-80.
[103] Sarwar, M., Attitall, I.H., Abdollahi, M. (2011). A review on the recent advances in pharmacological studies on medicinal plants; animal studies are done but clinical studies need completing. Asian Journal of Animal and Veterinary Advances, 6 (8), 867-883. doi: 10.3923/ajava.2011.867.883.
[104] Mitra, S.K., Gopumadhavan, S., Venkataranganna, M. V., et al. (1999). Anti-asthmatic and anti-anaphylactic effect of E-721B, An herbal formulation. Indian Journal of Pharmacology, 31(2), 133-137.
[105] Adeleye, O. A., Femi-Oyewo, M. N., Bamiro, O.A., et al. (2021). Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease. Futur J Pharm Sci, 7 (1).
doi: 10.1186/s43094-021-00223-5.
[106] Carr, A. C., Maggini, S. (2017). Vitamin C and immune function. Nutrients, 9 (11), 1211. doi: 10.3390/nu9111211.
[107] Sharma, V., Chaudhary, U. (2015). An overview on indigenous knowledge of Achyranthes aspera. J Crit Rev, 2 (1), 7-19.